These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 37190100)

  • 1. Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges.
    Kravchuk EV; Ashniev GA; Gladkova MG; Orlov AV; Vasileva AV; Boldyreva AV; Burenin AG; Skirda AM; Nikitin PI; Orlova NN
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEEPSEN: a convolutional neural network based method for super-enhancer prediction.
    Bu H; Hao J; Gan Y; Zhou S; Guan J
    BMC Bioinformatics; 2019 Dec; 20(Suppl 15):598. PubMed ID: 31874597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-enhancers in transcriptional regulation and genome organization.
    Wang X; Cairns MJ; Yan J
    Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super enhancer lncRNAs: a novel hallmark in cancer.
    Song P; Han R; Yang F
    Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status.
    Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Super-Enhancers for Disease Treatment and Diagnosis.
    Shin HY
    Mol Cells; 2018 Jun; 41(6):506-514. PubMed ID: 29754476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
    Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
    Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer.
    Kelly MR; Wisniewska K; Regner MJ; Lewis MW; Perreault AA; Davis ES; Phanstiel DH; Parker JS; Franco HL
    Nat Commun; 2022 Jul; 13(1):4247. PubMed ID: 35869079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super-enhancers complexes zoom in transcription in cancer.
    Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
    Jia Q; Chen S; Tan Y; Li Y; Tang F
    Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer.
    Flam EL; Danilova L; Kelley DZ; Stavrovskaya E; Guo T; Considine M; Qian J; Califano JA; Favorov A; Fertig EJ; Gaykalova DA
    Sci Rep; 2019 Oct; 9(1):15034. PubMed ID: 31636280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers.
    Shin HY
    Genes Genomics; 2019 Mar; 41(3):257-265. PubMed ID: 30456521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
    Glinsky GV
    Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.